DMD and Duchenne muscular dystrophy: Some patients with DMD show symptoms of developmental, cognitive, learning, and behavioral difficulties owing to the defect of dystrophin expressed in CNS18, however since PMO cannot cross the blood-brain barrier (BBB), it is not expected to have a therapeutic effect on these symptoms.